Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes

NCT00309608 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

333

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Linagliptin
DRUG: Linagliptin
DRUG: Linagliptin
DRUG: Placebo
DRUG: Glimepiride

Sponsor

Boehringer Ingelheim